Provided by Tiger Trade Technology Pte. Ltd.

TriSalus Life Sciences Inc.

4.74
+0.21504.76%
Volume:73.54K
Turnover:339.21K
Market Cap:236.58M
PE:-2.21
High:4.77
Open:4.42
Low:4.39
Close:4.52
52wk High:7.95
52wk Low:3.42
Shares:49.96M
Float Shares:39.49M
Volume Ratio:0.85
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1441
EPS(LYR):-1.3119
ROE:-496.21%
ROA:-61.10%
PB:-8.85
PE(LYR):-3.61

Loading ...

BRIEF-Trisalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky To Its Board Of Directors

Reuters
·
Feb 09

TriSalus Life Sciences appoints Stansky to board of directors

TIPRANKS
·
Feb 09

TriSalus Life Sciences Appoints Michael Stansky to Board

Reuters
·
Feb 09

TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to Its Board of Directors

THOMSON REUTERS
·
Feb 09

TriSalus Life Sciences (TLSI) Gets a Buy from Northland Securities

TIPRANKS
·
Jan 14

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Stryker (SYK)

TIPRANKS
·
Jan 14

Analysts’ Top Healthcare Picks: TriSalus Life Sciences (TLSI), Outset Medical (OM)

TIPRANKS
·
Jan 13

TriSalus Posts $13.2M Q4 Revenue Vs $12.68M Est, $45.2M for 2025 Vs $44.62M Est, Guides $60M–$62M Sales in 2026 Vs $63.77M Est

Benzinga
·
Jan 12

TriSalus Life Sciences Projects 2026 Revenue of $60 Million to $62 Million

Reuters
·
Jan 12

TriSalus Life Sciences Inc - 2026 Revenue Guidance Set at $60-$62 Mln

THOMSON REUTERS
·
Jan 12

TriSalus Life Sciences Inc - Preliminary Revenue for the Fourth Quarter of About $13.2 Mln

THOMSON REUTERS
·
Jan 12

TriSalus Life Sciences named a 2026 Top Pick at Northland

TIPRANKS
·
Jan 08

TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Dec 18, 2025

TriSalus Life Sciences Hosts Virtual KOL Event on TriNav Infusion System for Symptomatic Thyroid Disease

Reuters
·
Dec 05, 2025

TriSalus Life Sciences Launches New Drug Delivery System

MT Newswires Live
·
Nov 18, 2025

BRIEF-Trisalus Life Sciences Launches Trinav® Xp Infusion System To Expand Options For Pressure-Enabled Drug Delivery™

Reuters
·
Nov 18, 2025

TriSalus Life Sciences Launches Trinav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™

THOMSON REUTERS
·
Nov 18, 2025

BRIEF-TriSalus Life Sciences Files For Mixed Shelf Of Up To $150 Million - SEC Filing

Reuters
·
Nov 14, 2025

TriSalus Life Sciences Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing

THOMSON REUTERS
·
Nov 14, 2025

TriSalus Life Sciences reports third quarter revenue of $11.6 million, up 57% year-over-year

Reuters
·
Nov 14, 2025